Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer

International Journal of Hyperthermia

Volumn 17, Issue 1, 2001, Pages 31-37

  Hurwitz, M D ^a   Kaplan, I D ^a   Svensson, G K ^a   Hynynen, K ^a   Hansen, M S ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Hyperthermia; Prostate cancer; Radiation

Indexed keywords

ANTIANDROGEN; FLUTAMIDE; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN; NILUTAMIDE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BEAM THERAPY; BODY POSITION; BONE PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; DYSURIA; FEASIBILITY STUDY; HEMATURIA; HORMONE SUBSTITUTION; HOSPITAL BED; HUMAN; HYPERTHERMIC THERAPY; MALE; MUCOSA INFLAMMATION; PATIENT POSITIONING; PATIENT SATISFACTION; PROSTATE CANCER; RADIATION APPLICATOR; RADIATION DOSE; RECTUM MUCOSA; RECTUM TEMPERATURE; SEDATION; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME;

EID: 0035181714     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/02656730150201570     Document Type: Article

References (10)

1. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate
2. Phase I/II study of external radio frequency phased array hyperthermia and external beam radiotherapy in the treatment of prostate cancer: Technique and results of intraprostatic temperature measurements
3. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
4. Phase I/II study, combination of radiotherapy and hyperthermia in patients with deep-seated malignant tumors: Report of a pilot study by the Radiation Therapy Oncology Group
5. Phase III study of interstitial thermoradiotherapy compared with radiotherapy alone in the treatment of recurrent or persistant human tumors. A prospective controlled randomized study by the Radiation Therapy Group
6. Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate
7. Ultrasound heating technology
8. A phase I/II study to evaluate radiation therapy and hyperthermia for deep-seated tumors: A report of RTOG 89-08
9. Phase III trial of androgen supression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of the Radiation Therapy Oncology Group protocol 85-31
10. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma - A randomized comparative trial of the radiation therapy oncology group